Cargando…
Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double‐blind, placebo‐controlled, crossover study, with an open‐label extension
INTRODUCTION: Cerebral glucose and insulin metabolism is impaired in Alzheimer's disease (AD). Ketones provide alternative energy. Will medium chain triglyceride (MCT) oil, a nutritional source of ketones, impact cognition in AD? METHODS: This was a 6‐month randomized, double‐blind, placebo‐con...
Autores principales: | Juby, Angela G., Blackburn, Toni E., Mager, Diana R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919247/ https://www.ncbi.nlm.nih.gov/pubmed/35310527 http://dx.doi.org/10.1002/trc2.12259 |
Ejemplares similares
-
Medium chain triglycerides (MCT) formulas in paediatric and allergological practice
por: Łoś-Rycharska, Ewa, et al.
Publicado: (2016) -
Effects of Wall Material on Medium-Chain Triglyceride (MCT) Oil Microcapsules Prepared by Spray Drying
por: San, Su Mon, et al.
Publicado: (2022) -
Medium Chain Triglyceride (MCT) Oil Affects the Immunophenotype via Reprogramming of Mitochondrial Respiration in Murine Macrophages
por: Yu, Seungmin, et al.
Publicado: (2019) -
Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil
por: Berk, Benjamin Andreas, et al.
Publicado: (2022) -
Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis
por: Juby, Angela G., et al.
Publicado: (2023)